AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 132 filers reported holding AKEBIA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.59 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $341,000 | -96.6% | 475,500 | -35.2% | 0.00% | -98.5% |
Q2 2020 | $9,968,000 | -33.4% | 734,028 | -62.8% | 0.06% | -46.7% |
Q1 2020 | $14,965,000 | +0.4% | 1,974,320 | -16.3% | 0.12% | +56.4% |
Q4 2019 | $14,903,000 | +114.5% | 2,358,100 | +33.1% | 0.08% | +81.4% |
Q3 2019 | $6,947,000 | -11.6% | 1,772,300 | +9.2% | 0.04% | +4.9% |
Q2 2019 | $7,857,000 | +859.3% | 1,623,400 | +1523.4% | 0.04% | +925.0% |
Q1 2019 | $819,000 | -70.6% | 100,000 | -80.2% | 0.00% | -71.4% |
Q4 2018 | $2,789,000 | +5.9% | 504,373 | +69.1% | 0.01% | +27.3% |
Q3 2018 | $2,633,000 | +42.3% | 298,212 | +53.6% | 0.01% | +37.5% |
Q1 2018 | $1,850,000 | +184900.0% | 194,150 | +194050.0% | 0.01% | – |
Q1 2016 | $1,000 | -99.8% | 100 | -99.8% | 0.00% | -100.0% |
Q4 2015 | $543,000 | – | 42,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Alerce Investment Management, L.P. | 4,652,561 | $3,340,000 | 5.66% |
Orchard Capital Management, LLC | 1,762,731 | $1,265,000 | 0.36% |
Ikarian Capital, LLC | 1,200,000 | $860,000 | 0.11% |
Ikarian Capital, LLC | 800,000 | $575,000 | 0.08% |
XTX Topco Ltd | 102,392 | $74,000 | 0.03% |
Nantahala Capital Management | 965,800 | $693,000 | 0.03% |
Worth Venture Partners, LLC | 63,500 | $46,000 | 0.02% |
Ardent Capital Management, Inc. | 43,429 | $31,000 | 0.02% |
Virtus ETF Advisers LLC | 65,149 | $47,000 | 0.02% |
RICE HALL JAMES & ASSOCIATES, LLC | 513,292 | $368,000 | 0.02% |